25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MRMD (Marimed Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Marimed Inc together

I guess you are interested in Marimed Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Marimed Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Marimed Inc’s Price Targets

I'm going to help you getting a better view of Marimed Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Marimed Inc

I send you an email if I find something interesting about Marimed Inc.

1. Quick Overview

1.1. Quick analysis of Marimed Inc (30 sec.)










1.2. What can you expect buying and holding a share of Marimed Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
97.1%

What is your share worth?

Current worth
$0.15
Expected worth in 1 year
$0.13
How sure are you?
64.7%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-27.0%

For what price can you sell your share?

Current Price per Share
$0.09
Expected price per share
$0.075 - $0.07
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Marimed Inc (5 min.)




Live pricePrice per Share (EOD)
$0.09
Intrinsic Value Per Share
$-0.56 - $-0.66
Total Value Per Share
$-0.41 - $-0.51

2.2. Growth of Marimed Inc (5 min.)




Is Marimed Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$59.2m$80.3m-$16.4m-25.8%

How much money is Marimed Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4m-$4.1m$91.5k2.2%
Net Profit Margin-10.5%-10.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Marimed Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Marimed Inc?

Welcome investor! Marimed Inc's management wants to use your money to grow the business. In return you get a share of Marimed Inc.

First you should know what it really means to hold a share of Marimed Inc. And how you can make/lose money.

Speculation

The Price per Share of Marimed Inc is $0.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Marimed Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Marimed Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.15. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Marimed Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-15.6%-0.01-11.6%-0.01-11.9%-0.01-5.8%0.00-1.2%-0.01-9.0%
Usd Book Value Change Per Share0.00-1.9%-0.01-6.9%-0.02-24.4%0.00-5.3%0.019.6%0.005.0%
Usd Dividend Per Share0.000.2%0.000.1%0.000.1%0.000.1%0.000.2%0.000.3%
Usd Total Gains Per Share0.00-1.7%-0.01-6.7%-0.02-24.3%0.00-5.1%0.019.8%0.005.2%
Usd Price Per Share0.09-0.14-0.35-0.30-0.43-0.84-
Price to Earnings Ratio-1.68--7.57--18.51--9.64--1.50--400.34-
Price-to-Total Gains Ratio-60.38--137.45--312.01--139.11--60.48-228.83-
Price to Book Ratio0.62-0.85-1.68-1.42-39.22-46.21-
Price-to-Total Gains Ratio-60.38--137.45--312.01--139.11--60.48-228.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.09
Number of shares11111
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.01
Usd Total Gains Per Share-0.010.01
Gains per Quarter (11111 shares)-67.4998.49
Gains per Year (11111 shares)-269.96393.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14-274-2809385384
29-549-55017771778
313-823-8202611561172
417-1097-10903415421566
522-1371-13604319271960
626-1646-16305123132354
730-1920-19006026982748
835-2194-21706830843142
939-2469-24407734693536
1043-2743-27108538543930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%9.011.00.045.0%13.021.00.038.2%13.021.00.038.2%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%12.08.00.060.0%21.013.00.061.8%21.013.00.061.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%33.00.01.097.1%33.00.01.097.1%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%12.08.00.060.0%22.012.00.064.7%22.012.00.064.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Marimed Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.006+262%-0.022+1187%-0.005+177%0.009-120%0.004-138%
Book Value Per Share--0.1520.164-7%0.206-26%0.203-25%0.168-10%0.128+19%
Current Ratio--1.0491.181-11%1.659-37%1.523-31%1.497-30%1.205-13%
Debt To Asset Ratio--0.7150.695+3%0.585+22%0.557+28%0.573+25%0.602+19%
Debt To Equity Ratio--2.4402.225+10%1.422+72%1.368+78%6.416-62%5.994-59%
Dividend Per Share--0.0000.000+53%0.000+37%0.000+36%0.000-22%0.000-39%
Enterprise Value---112200378.496-90383875.248-19%24395893.040-560%15506504.800-824%91790067.536-222%271159851.218-141%
Eps---0.014-0.010-25%-0.011-23%-0.005-63%-0.001-92%-0.008-42%
Ev To Sales Ratio---0.739-0.575-22%0.165-548%0.138-634%0.774-196%17.469-104%
Free Cash Flow Per Share--0.002-0.003+216%-0.003+232%-0.006+335%-0.001+129%-0.006+330%
Free Cash Flow To Equity Per Share---0.001-0.003+283%-0.002+227%-0.001-3%0.003-122%0.004-117%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.663----------
Intrinsic Value_10Y_min---0.559----------
Intrinsic Value_1Y_max---0.030----------
Intrinsic Value_1Y_min---0.029----------
Intrinsic Value_3Y_max---0.117----------
Intrinsic Value_3Y_min---0.111----------
Intrinsic Value_5Y_max---0.239----------
Intrinsic Value_5Y_min---0.219----------
Market Cap35030701.440-4%36587621.50454784124.752-33%134770893.040-73%116769004.800-69%167512921.986-78%328052215.838-89%
Net Profit Margin---0.144-0.105-27%-0.108-25%-0.050-65%-0.001-99%-0.628+337%
Operating Margin----0%0.025-100%0.051-100%0.130-100%-0.3610%
Operating Ratio--1.5841.598-1%1.345+18%1.270+25%1.115+42%1.127+40%
Pb Ratio0.592-4%0.6180.846-27%1.675-63%1.422-57%39.219-98%46.212-99%
Pe Ratio-1.606+4%-1.678-7.569+351%-18.507+1003%-9.637+474%-1.502-10%-400.343+23762%
Price Per Share0.090-4%0.0940.141-33%0.346-73%0.300-69%0.430-78%0.843-89%
Price To Free Cash Flow Ratio9.019-4%9.420-3.879+141%-14.988+259%-8.839+194%-2.172+123%-4.609+149%
Price To Total Gains Ratio-57.806+4%-60.376-137.448+128%-312.014+417%-139.108+130%-60.483+0%228.827-126%
Quick Ratio--0.1660.175-5%0.354-53%0.444-63%0.689-76%0.606-73%
Return On Assets---0.026-0.020-25%-0.021-18%-0.009-67%0.003-859%-0.047+80%
Return On Equity---0.089-0.065-27%-0.055-38%-0.035-61%0.117-176%-0.294+229%
Total Gains Per Share---0.002-0.006+290%-0.022+1303%-0.005+197%0.009-118%0.005-133%
Usd Book Value--59212000.00063883000.000-7%80350750.000-26%79145333.333-25%65575443.200-10%49858207.217+19%
Usd Book Value Change Per Share---0.002-0.006+262%-0.022+1187%-0.005+177%0.009-120%0.004-138%
Usd Book Value Per Share--0.1520.164-7%0.206-26%0.203-25%0.168-10%0.128+19%
Usd Dividend Per Share--0.0000.000+53%0.000+37%0.000+36%0.000-22%0.000-39%
Usd Enterprise Value---112200378.496-90383875.248-19%24395893.040-560%15506504.800-824%91790067.536-222%271159851.218-141%
Usd Eps---0.014-0.010-25%-0.011-23%-0.005-63%-0.001-92%-0.008-42%
Usd Free Cash Flow--971000.000-1123250.000+216%-1279250.000+232%-2280166.667+335%-283504.350+129%-2237001.783+330%
Usd Free Cash Flow Per Share--0.002-0.003+216%-0.003+232%-0.006+335%-0.001+129%-0.006+330%
Usd Free Cash Flow To Equity Per Share---0.001-0.003+283%-0.002+227%-0.001-3%0.003-122%0.004-117%
Usd Market Cap35030701.440-4%36587621.50454784124.752-33%134770893.040-73%116769004.800-69%167512921.986-78%328052215.838-89%
Usd Price Per Share0.090-4%0.0940.141-33%0.346-73%0.300-69%0.430-78%0.843-89%
Usd Profit---5452000.000-4079500.000-25%-4171000.000-23%-2030583.333-63%-419452.300-92%-3136575.369-42%
Usd Revenue--37955000.00039496500.000-4%38037750.0000%37270416.667+2%32171014.500+18%21061204.820+80%
Usd Total Gains Per Share---0.002-0.006+290%-0.022+1303%-0.005+197%0.009-118%0.005-133%
 EOD+4 -4MRQTTM+15 -22YOY+14 -243Y+13 -255Y+9 -2910Y+13 -24

3.3 Fundamental Score

Let's check the fundamental score of Marimed Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.606
Price to Book Ratio (EOD)Between0-10.592
Net Profit Margin (MRQ)Greater than0-0.144
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.166
Current Ratio (MRQ)Greater than11.049
Debt to Asset Ratio (MRQ)Less than10.715
Debt to Equity Ratio (MRQ)Less than12.440
Return on Equity (MRQ)Greater than0.15-0.089
Return on Assets (MRQ)Greater than0.05-0.026
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Marimed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.138
Ma 20Greater thanMa 500.072
Ma 50Greater thanMa 1000.083
Ma 100Greater thanMa 2000.096
OpenGreater thanClose0.068
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Marimed Inc

MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States and internationally. The company sells cannabis flower, vapes, and concentrates under the Nature's Heritage brand; cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty's Eddies brand; and cannabis-infused ice creams under Emack & Bolio's brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under InHouse brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-30 21:28:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Marimed Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -14.4%Β means thatΒ $-0.14 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Marimed Inc:

  • The MRQ is -14.4%. The company is making a huge loss. -2
  • The TTM is -10.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.4%TTM-10.5%-3.9%
TTM-10.5%YOY-10.8%+0.3%
TTM-10.5%5Y-0.1%-10.4%
5Y-0.1%10Y-62.8%+62.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Marimed Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means thatΒ Marimed Inc generatedΒ $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Marimed Inc:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.0%-0.7%
TTM-2.0%YOY-2.1%+0.2%
TTM-2.0%5Y0.3%-2.3%
5Y0.3%10Y-4.7%+5.1%
4.3.1.3. Return on Equity

Shows how efficient Marimed Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -8.9% Return on Equity means Marimed Inc generated $-0.09Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Marimed Inc:

  • The MRQ is -8.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.9%TTM-6.5%-2.4%
TTM-6.5%YOY-5.5%-1.0%
TTM-6.5%5Y11.7%-18.2%
5Y11.7%10Y-29.4%+41.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Marimed Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Marimed Inc is operatingΒ .

  • Measures how much profit Marimed Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Marimed Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.5%-2.5%
TTM-5Y13.0%-13.0%
5Y13.0%10Y-36.1%+49.1%
4.3.2.2. Operating Ratio

Measures how efficient Marimed Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.58 means that the operating costs are $1.58 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Marimed Inc:

  • The MRQ is 1.584. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.598. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.584TTM1.598-0.014
TTM1.598YOY1.345+0.253
TTM1.5985Y1.115+0.483
5Y1.11510Y1.127-0.013
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Marimed Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Marimed Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.05Β means the company has $1.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Marimed Inc:

  • The MRQ is 1.049. The company is just able to pay all its short-term debts.
  • The TTM is 1.181. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.181-0.132
TTM1.181YOY1.659-0.478
TTM1.1815Y1.497-0.316
5Y1.49710Y1.205+0.292
4.4.3.2. Quick Ratio

Measures if Marimed Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.17Β means the company can pay off $0.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Marimed Inc:

  • The MRQ is 0.166. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.175. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.166TTM0.175-0.009
TTM0.175YOY0.354-0.179
TTM0.1755Y0.689-0.514
5Y0.68910Y0.606+0.084
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Marimed Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Marimed IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Marimed Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.72Β means that Marimed Inc assets areΒ financed with 71.5% credit (debt) and the remaining percentage (100% - 71.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Marimed Inc:

  • The MRQ is 0.715. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.695. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.715TTM0.695+0.021
TTM0.695YOY0.585+0.109
TTM0.6955Y0.573+0.122
5Y0.57310Y0.602-0.029
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Marimed Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 244.0% means that company has $2.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Marimed Inc:

  • The MRQ is 2.440. The company is just not able to pay all its debts with equity.
  • The TTM is 2.225. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.440TTM2.225+0.215
TTM2.225YOY1.422+0.802
TTM2.2255Y6.416-4.192
5Y6.41610Y5.994+0.422
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Marimed Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Marimed Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.68 means the investor is paying $-1.68Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Marimed Inc:

  • The EOD is -1.606. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.678. Based on the earnings, the company is expensive. -2
  • The TTM is -7.569. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.606MRQ-1.678+0.071
MRQ-1.678TTM-7.569+5.891
TTM-7.569YOY-18.507+10.938
TTM-7.5695Y-1.502-6.067
5Y-1.50210Y-400.343+398.841
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Marimed Inc:

  • The EOD is 9.019. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.420. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -3.879. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.019MRQ9.420-0.401
MRQ9.420TTM-3.879+13.299
TTM-3.879YOY-14.988+11.109
TTM-3.8795Y-2.172-1.707
5Y-2.17210Y-4.609+2.438
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Marimed Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.62 means the investor is paying $0.62Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Marimed Inc:

  • The EOD is 0.592. Based on the equity, the company is cheap. +2
  • The MRQ is 0.618. Based on the equity, the company is cheap. +2
  • The TTM is 0.846. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.592MRQ0.618-0.026
MRQ0.618TTM0.846-0.229
TTM0.846YOY1.675-0.829
TTM0.8465Y39.219-38.373
5Y39.21910Y46.212-6.993
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets208,000
Total Liabilities148,788
Total Stockholder Equity60,990
 As reported
Total Liabilities 148,788
Total Stockholder Equity+ 60,990
Total Assets = 208,000

Assets

Total Assets208,000
Total Current Assets58,002
Long-term Assets149,998
Total Current Assets
Cash And Cash Equivalents 7,001
Net Receivables 9,182
Inventory 37,560
Other Current Assets 4,007
Total Current Assets  (as reported)58,002
Total Current Assets  (calculated)57,750
+/- 252
Long-term Assets
Property Plant Equipment 106,896
Goodwill 19,482
Intangible Assets 21,690
Long-term Assets Other 1,116
Long-term Assets  (as reported)149,998
Long-term Assets  (calculated)149,184
+/- 814

Liabilities & Shareholders' Equity

Total Current Liabilities55,308
Long-term Liabilities93,480
Total Stockholder Equity60,990
Total Current Liabilities
Short Long Term Debt 4,786
Accounts payable 13,969
Total Current Liabilities  (as reported)55,308
Total Current Liabilities  (calculated)18,755
+/- 36,553
Long-term Liabilities
Long term Debt 69,474
Capital Lease Obligations Min Short Term Debt13,254
Long-term Liabilities Other 100
Long-term Liabilities  (as reported)93,480
Long-term Liabilities  (calculated)82,828
+/- 10,652
Total Stockholder Equity
Total Stockholder Equity (as reported)60,990
Total Stockholder Equity (calculated)0
+/- 60,990
Other
Capital Stock389
Common Stock Shares Outstanding 388,710
Net Debt 67,259
Net Invested Capital 135,250
Net Working Capital 2,694
Property Plant and Equipment Gross 128,867



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
8,563
10,850
15,351
28,375
25,669
33,938
45,441
57,133
82,961
97,625
133,676
137,056
61,572
65,342
67,832
72,451
76,445
89,985
102,874
118,237
123,205
136,982
135,878
144,698
152,202
184,391
189,368
190,817
196,123
201,332
208,534
212,681
206,989
208,000
208,000206,989212,681208,534201,332196,123190,817189,368184,391152,202144,698135,878136,982123,205118,237102,87489,98576,44572,45167,83265,34261,572137,056133,67697,62582,96157,13345,44133,93825,66928,37515,35110,8508,563
   > Total Current Assets 
2,741
3,300
5,789
5,141
4,056
5,659
12,265
15,520
15,709
19,230
48,056
51,725
7,377
10,433
12,619
16,913
21,043
31,693
39,760
49,786
44,613
54,314
33,550
40,883
44,146
59,374
57,917
50,792
51,432
54,895
53,054
56,680
53,509
58,002
58,00253,50956,68053,05454,89551,43250,79257,91759,37444,14640,88333,55054,31444,61349,78639,76031,69321,04316,91312,61910,4337,37751,72548,05619,23015,70915,52012,2655,6594,0565,1415,7893,3002,741
       Cash And Cash Equivalents 
569
640
2,816
867
1,028
410
5,077
6,027
4,104
4,216
3,530
137
739
1,855
2,340
2,261
2,999
12,319
17,357
25,581
29,683
33,467
7,911
11,113
9,737
21,595
14,635
13,259
14,645
15,234
10,192
9,788
7,282
7,001
7,0017,2829,78810,19215,23414,64513,25914,63521,5959,73711,1137,91133,46729,68325,58117,35712,3192,9992,2612,3401,8557391373,5304,2164,1046,0275,0774101,0288672,816640569
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
1,449
762
785
1,003
1,357
1,312
942
420
251
1,253
525
274
123
104
102
161
88
0
0
0
0
0
00000881611021041232745251,2532514209421,3121,3571,0037857621,449000000000000
       Net Receivables 
1,934
2,103
2,901
4,165
2,743
4,873
6,786
9,035
7,525
7,134
33,840
43,371
3,777
4,927
5,379
6,597
9,274
9,592
10,278
10,579
3,471
5,177
6,166
7,419
7,527
9,011
8,853
6,352
7,199
6,491
7,744
7,321
8,742
9,182
9,1828,7427,3217,7446,4917,1996,3528,8539,0117,5277,4196,1665,1773,47110,57910,2789,5929,2746,5975,3794,9273,77743,37133,8407,1347,5259,0356,7864,8732,7434,1652,9012,1031,934
       Other Current Assets 
237
557
72
109
285
376
402
458
4,079
171
170
212
192
173
209
250
583
1,016
1,955
2,213
1,441
2,179
3,059
3,768
7,282
18,237
9,541
6,026
3,512
3,281
3,101
3,667
3,389
4,007
4,0073,3893,6673,1013,2813,5126,0269,54118,2377,2823,7683,0592,1791,4412,2131,9551,0165832502091731922121701714,07945840237628510972557237
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
78,395
85,620
85,331
54,195
54,909
55,213
55,538
55,402
58,291
63,114
68,451
78,592
82,668
102,328
103,815
108,056
112,721
131,451
140,025
144,691
146,437
155,480
156,001
153,480
149,998
149,998153,480156,001155,480146,437144,691140,025131,451112,721108,056103,815102,32882,66878,59268,45163,11458,29155,40255,53855,21354,90954,19585,33185,62078,395000000000
       Property Plant Equipment 
5,279
7,016
8,661
21,965
20,689
27,169
31,365
32,769
34,100
41,625
43,718
46,193
48,691
49,441
50,231
50,976
45,637
47,490
52,666
59,516
62,150
65,482
69,132
76,097
77,285
84,707
90,795
97,591
102,114
103,760
107,347
108,751
106,970
106,896
106,896106,970108,751107,347103,760102,11497,59190,79584,70777,28576,09769,13265,48262,15059,51652,66647,49045,63750,97650,23149,44148,69146,19343,71841,62534,10032,76931,36527,16920,68921,9658,6617,0165,279
       Goodwill 
0
0
0
0
265
0
0
452
0
0
0
0
0
0
0
0
0
0
0
0
2,068
2,068
8,079
8,079
8,079
12,004
11,993
11,993
11,993
15,812
15,812
15,812
15,812
19,482
19,48215,81215,81215,81215,81211,99311,99311,99312,0048,0798,0798,0792,0682,068000000000000452002650000
       Long Term Investments 
543
534
596
784
461
567
0
100
1,672
34,118
35,662
32,729
1,325
1,325
1,034
1,086
2,131
2,379
2,360
1,188
8,987
9,204
9,116
9,160
7,467
7,523
8,546
164
221
274
0
0
0
0
00002742211648,5467,5237,4679,1609,1169,2048,9871,1882,3602,3792,1311,0861,0341,3251,32532,72935,66234,1181,6721000567461784596534543
       Intangible Assets 
0
0
0
0
0
0
0
0
185
123
3,424
3,592
0
0
0
0
2,229
2,690
2,521
2,349
2,230
2,395
9,898
9,469
14,201
19,480
18,700
17,856
17,012
12,819
20,404
19,522
18,639
21,690
21,69018,63919,52220,40412,81917,01217,85618,70019,48014,2019,4699,8982,3952,2302,3492,5212,6902,22900003,5923,42412318500000000
       Other Assets 
0
0
901
1,269
658
1,110
1,811
8,293
31,295
2,529
2,817
2,818
1,815
1,851
1,496
1,165
1,046
1,311
1,292
1,286
9,085
9,202
9,607
10,170
8,491
0
9,874
0
0
0
0
0
0
0
00000009,87408,49110,1709,6079,2029,0851,2861,2921,3111,0461,1651,4961,8511,8152,8182,8172,52931,2958,2931,8111,1106581,26990100
> Total Liabilities 
9,672
10,658
10,083
17,641
16,895
23,205
23,799
20,632
21,196
32,103
50,851
54,263
55,244
73,643
72,262
72,367
53,620
37,558
40,381
45,209
49,181
55,670
50,700
55,096
57,167
81,397
86,562
110,955
126,209
132,511
139,931
144,840
147,113
148,788
148,788147,113144,840139,931132,511126,209110,95586,56281,39757,16755,09650,70055,67049,18145,20940,38137,55853,62072,36772,26273,64355,24454,26350,85132,10321,19620,63223,79923,20516,89517,64110,08310,6589,672
   > Total Current Liabilities 
7,137
8,004
8,143
9,767
12,294
16,938
16,087
12,895
9,889
15,035
31,083
35,497
36,720
34,659
34,115
26,003
23,227
14,554
18,885
22,462
27,223
34,185
25,213
27,251
26,490
24,509
29,225
35,292
30,862
35,455
40,659
44,597
48,678
55,308
55,30848,67844,59740,65935,45530,86235,29229,22524,50926,49027,25125,21334,18527,22322,46218,88514,55423,22726,00334,11534,65936,72035,49731,08315,0359,88912,89516,08716,93812,2949,7678,1438,0047,137
       Short-term Debt 
4,643
5,011
6,683
2,582
95
120
0
0
0
0
0
21,294
23,337
0
0
0
8,859
5
10
10
10
10
0
0
3,774
3,300
3,600
0
0
0
0
0
0
0
00000003,6003,3003,774001010101058,85900023,33721,29400000120952,5826,6835,0114,643
       Short Long Term Debt 
4,643
5,011
6,683
2,582
95
120
121
121
125
10,597
21,083
21,294
23,337
21,452
22,853
12,820
11,279
1,387
1,360
1,422
1,410
1,426
2,734
2,825
3,774
6,073
5,650
4,609
723
1,057
3,871
4,371
5,126
4,786
4,7865,1264,3713,8711,0577234,6095,6506,0733,7742,8252,7341,4261,4101,4221,3601,38711,27912,82022,85321,45223,33721,29421,08310,597125121121120952,5826,6835,0114,643
       Accounts payable 
2,267
2,766
1,825
5,418
2,257
2,721
2,834
2,633
3,915
1,940
2,169
3,387
4,719
4,740
4,587
6,293
9,824
12,000
16,374
19,912
24,712
31,453
21,098
22,901
21,206
16,416
21,095
8,494
9,001
10,256
11,854
12,983
13,189
13,969
13,96913,18912,98311,85410,2569,0018,49421,09516,41621,20622,90121,09831,45324,71219,91216,37412,0009,8246,2934,5874,7404,7193,3872,1691,9403,9152,6332,8342,7212,2575,4181,8252,7662,267
       Other Current Liabilities 
227
227
593
425
320
3,437
2,789
4,065
382
13
3,163
198
858
1,642
1,254
1,505
4,543
2,549
2,502
2,540
2,500
2,722
4,115
4,350
1,510
35,071
35,323
0
0
0
0
0
0
0
000000035,32335,0711,5104,3504,1152,7222,5002,5402,5022,5494,5431,5051,2541,6428581983,163133824,0652,7893,437320425593227227
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
17,068
19,768
18,766
18,523
38,984
38,147
46,364
30,393
23,004
21,495
22,747
21,958
21,485
25,487
27,845
30,677
26,610
26,544
75,663
95,347
97,056
99,272
100,243
98,435
93,480
93,48098,435100,24399,27297,05695,34775,66326,54426,61030,67727,84525,48721,48521,95822,74721,49523,00430,39346,36438,14738,98418,52318,76619,76817,068000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,682
3,236
2,015
926
448
46
0
0
25,943
0
0
0
0
0
0
0
0
0
00000000025,94300464489262,0153,23610,6820000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,725
75,450
75,450
75,450
75,450
75,450
75,450
75,450
75,450
75,450
43,804
0
0
0
0
0
0
0
000000043,80475,45075,45075,45075,45075,45075,45075,45075,45075,45014,7250000000000000000
       Other Liabilities 
0
0
15
21
191
240
240
294
338
169
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
0
100
0
0
0
0
0
0
0
00000001000100100100100100100100100100100100100100100100169338294240240191211500
> Total Stockholder Equity
-1,108
192
4,612
9,758
8,634
10,559
21,659
36,610
61,984
65,814
81,995
81,944
6,882
-7,730
-3,866
673
23,392
90,721
100,793
112,318
113,312
120,648
124,359
128,807
134,271
142,283
126,301
81,512
71,564
70,511
70,318
69,577
61,628
60,990
60,99061,62869,57770,31870,51171,56481,512126,301142,283134,271128,807124,359120,648113,312112,318100,79390,72123,392673-3,866-7,7306,88281,94481,99565,81461,98436,61021,65910,5598,6349,7584,612192-1,108
   Common Stock
64
64
162
221
141
180
194
203
211
212
216
218
228
235
271
290
314
323
327
332
334
336
339
339
341
348
372
0
0
0
0
0
0
0
00000003723483413393393363343323273233142902712352282182162122112031941801412211626464
   Retained Earnings Total Equity0000000-85,527-84,569-83,924-88,675-91,381-93,204-97,392-90,884-92,904-100,397-104,6170000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
112,974
115,340
117,920
127,231
134,920
138,064
139,951
141,652
142,365
151,052
167,652
0
0
0
0
0
0
0
0000000167,652151,052142,365141,652139,951138,064134,920127,231117,920115,340112,9740000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
1,147
1,154
1,147
1,901
2,010
2,728
8,521
16,414
169
0
2,080
4,958
1,168
5
5
5
-5
5
0
189
0
2
0
41
39
2
0
0
0
0
0
0
0
0
000000002394102018905-55551,1684,9582,080016916,4148,5212,7282,0101,9011,1471,1541,147



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue157,964
Cost of Revenue-95,096
Gross Profit62,86862,868
 
Operating Income (+$)
Gross Profit62,868
Operating Expense-154,437
Operating Income3,527-91,569
 
Operating Expense (+$)
Research Development0
Selling General Administrative59,341
Selling And Marketing Expenses0
Operating Expense154,43759,341
 
Net Interest Income (+$)
Interest Income114
Interest Expense-6,944
Other Finance Cost-0
Net Interest Income-6,830
 
Pretax Income (+$)
Operating Income3,527
Net Interest Income-6,830
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,9684,192
EBIT - interestExpense = -6,944
-12,164
-5,220
Interest Expense6,944
Earnings Before Interest and Taxes (EBIT)02,976
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,968
Tax Provision-8,159
Net Income From Continuing Ops-12,127-12,127
Net Income-12,164
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-6656,830
 

Technical Analysis of Marimed Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Marimed Inc. The general trend of Marimed Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Marimed Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Marimed Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Marimed Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.068 < 0.07 < 0.07.

The bearish price targets are: 0.089 > 0.075 > 0.075.

Know someone who trades $MRMD? Share this with them.πŸ‘‡

Marimed Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Marimed Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Marimed Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Marimed Inc. The current macd is -0.00179261.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Marimed Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Marimed Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Marimed Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Marimed Inc Daily Moving Average Convergence/Divergence (MACD) ChartMarimed Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Marimed Inc. The current adx is 14.22.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Marimed Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Marimed Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Marimed Inc. The current sar is 0.067.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Marimed Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Marimed Inc. The current rsi is 66.14. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Marimed Inc Daily Relative Strength Index (RSI) ChartMarimed Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Marimed Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Marimed Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Marimed Inc Daily Stochastic Oscillator ChartMarimed Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Marimed Inc. The current cci is 365.52.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Marimed Inc Daily Commodity Channel Index (CCI) ChartMarimed Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Marimed Inc. The current cmo is 53.07.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Marimed Inc Daily Chande Momentum Oscillator (CMO) ChartMarimed Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Marimed Inc. The current willr is -19.29824561.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Marimed Inc Daily Williams %R ChartMarimed Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Marimed Inc.

Marimed Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Marimed Inc. The current atr is 0.00787798.

Marimed Inc Daily Average True Range (ATR) ChartMarimed Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Marimed Inc. The current obv is -23,588,685.

Marimed Inc Daily On-Balance Volume (OBV) ChartMarimed Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Marimed Inc. The current mfi is 59.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Marimed Inc Daily Money Flow Index (MFI) ChartMarimed Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Marimed Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Marimed Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Marimed Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.138
Ma 20Greater thanMa 500.072
Ma 50Greater thanMa 1000.083
Ma 100Greater thanMa 2000.096
OpenGreater thanClose0.068
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Marimed Inc with someone you think should read this too:
  • Are you bullish or bearish on Marimed Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Marimed Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Marimed Inc

I send you an email if I find something interesting about Marimed Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Marimed Inc.

Receive notifications about Marimed Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.